Louise

Proteomic & genomic electrochemical sensors, microfluidic cartridges, sample preparation technologies and user instrumentation

The clinical, biochemical and genetic data generated in the PoCCardio clinical trial are used to develop a computational AI-based tool for predicting the risk of a heart attack and therapy response in patients.

13 out of 29 study centres in Austria, Germany and Poland have begun recruiting participants for the trial of the PoCCardio point-of-care solution.

The paper was prepared by the Medical University of Graz for the CIBB 2024 conference on Computational Intelligence methods for Bioinformatics and Biostatistics.

PoCCardio welcomes the Bioinformatics Department at CING - The Cyprus Institute of Neurology and Genetics

Have a look at our leaflet

Mobile device to replace laboratory tests